NCT06695156Completed
Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency, Intensity, and Functionality: A Single-Arm Study
Source: ClinicalTrials.gov · Last updated 16 Jul 2026
Brief summary (registry, in English)
This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 2 Nov 2024
- Start date
- 28 Aug 2024
- Primary completion date
- 30 May 2026
- Lead sponsor
- Maharishi International University
- Diseases
- Migraine
- NCT number
- NCT06695156
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 28 Aug 2024 to the primary completion date, 30 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Medication overuse headache (MOH)
- Unwilling to maintain stable migraine medication dosages
Other illness
- Pre-diagnosed major systemic illness or unstable medical/psychiatric condition (eg, suicide risk) requiring immediate treatment or that could compromise protocol adherence
- Failure to complete baseline headache logs.
Age
- \> 60 years old or \< 18 Years old
Other
- Already practicing Transcendental Meditation.
- Current/planned pregnancy or breastfeeding
- New prophylactic migraine medicine started within 4 weeks of the screening visit
Who the study is looking for
- Diagnosis of migraine with or without aura, based on ICHD3 criteria
- 4 and above migraine days/month.
- · Episodic (4-14) vs chronic migraine (15+)
- ≥ one-year history of migraines starting before the age of 50.
- ≥ 18 years old or ≤ 60 Years old
- Willing to attend follow-up sessions.
- Willing to practice TM twice a day for 20 minutes.
- Fluent in English.
- Willing to continue the same medication without any additional medicine
- In good general health, with no other diseases expected to interfere with the study.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Georgetown Headache Center and DC area Coordinator of this site? Confirm its status | Washington D.C. | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.